BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38192998)

  • 1. Suppression of hepatocellular carcinoma progression by long noncoding RNA apolipoprotein C1 pseudogene via the regulation of the microRNA-106b-PTEN axis.
    Qian Y; Chen H; Chen L; Ge C; Zhu D; Zhou D
    Transl Cancer Res; 2023 Dec; 12(12):3752-3763. PubMed ID: 38192998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
    Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
    Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA PTENP1 inhibits cervical cancer progression by suppressing miR-106b.
    Fan Y; Sheng W; Meng Y; Cao Y; Li R
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):393-407. PubMed ID: 31913710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA TCL6 binds to miR-106a-5p to regulate hepatocellular carcinoma cells through PI3K/AKT signaling pathway.
    Luo LH; Jin M; Wang LQ; Xu GJ; Lin ZY; Yu DD; Yang SL; Ran RZ; Wu G; Zhang T
    J Cell Physiol; 2020 Sep; 235(9):6154-6166. PubMed ID: 32020591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA LOC107985656 represses the proliferation of hepatocellular carcinoma cells through activation of the tumor-suppressive Hippo pathway.
    Zeng Y; Xu Q; Xu N
    Bioengineered; 2021 Dec; 12(1):7964-7974. PubMed ID: 34565286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
    Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
    Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
    [No Abstract]   [Full Text] [Related]  

  • 7. miR-382-5p promotes cell invasion in hepatocellular carcinoma by targeting PTEN to activate PI3K/Akt signaling pathway.
    Lv B; Liu X; Zhu X; Huang M
    World J Surg Oncol; 2022 Jun; 20(1):175. PubMed ID: 35655254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-106b-5p promotes stem cell-like properties of hepatocellular carcinoma cells by targeting PTEN via PI3K/Akt pathway.
    Shi DM; Bian XY; Qin CD; Wu WZ
    Onco Targets Ther; 2018; 11():571-585. PubMed ID: 29416358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-3651 promotes the growth and invasion of hepatocellular carcinoma cells by targeting PTEN.
    Zhao X; Song Q; Miao G; Zhu X
    Onco Targets Ther; 2019; 12():7045-7054. PubMed ID: 31695418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-106b-5p Inhibits Tumor Necrosis Factor-α-induced Apoptosis by Targeting Phosphatase and Tensin Homolog Deleted on Chromosome 10 in Vascular Endothelial Cells.
    Zhang J; Li SF; Chen H; Song JX
    Chin Med J (Engl); 2016 Jun; 129(12):1406-12. PubMed ID: 27270534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
    Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
    Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-106b-5p promotes hepatocellular carcinoma development via modulating FOG2.
    Yu LX; Zhang BL; Yang MY; Liu H; Xiao CH; Zhang SG; Liu R
    Onco Targets Ther; 2019; 12():5639-5647. PubMed ID: 31406464
    [No Abstract]   [Full Text] [Related]  

  • 13. miR-106b-5p promotes aggressive progression of hepatocellular carcinoma via targeting RUNX3.
    Gu H; Gu S; Zhang X; Zhang S; Zhang D; Lin J; Hasengbayi S; Han W
    Cancer Med; 2019 Nov; 8(15):6756-6767. PubMed ID: 31503422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of LncRNA ANRIL Potential in Hepatic Cancer Progression.
    Ji Y; Sun H; Liang H; Wang Y; Lu M; Guo Z; Lv Z; Ren W
    J Environ Pathol Toxicol Oncol; 2019; 38(2):119-131. PubMed ID: 31679275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA GAS5 regulates epithelial-mesenchymal transition and viability of glioma cells by targeting microRNA-106b and regulating PTEN expression.
    Zhu XP; Pan SA; Chu Z; Zhou YX; Huang YK; Han DQ
    Neurosci Res; 2021 Sep; 170():32-40. PubMed ID: 32991951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Noncoding RNA GATA3-AS1 Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Suppression of PTEN, CDKN1A, and TP53.
    Luo X; Zhou N; Wang L; Zeng Q; Tang H
    Can J Gastroenterol Hepatol; 2019; 2019():1389653. PubMed ID: 31871924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA HOTAIR inhibits the progression of fibroblast-like synoviocytes by sponging miRNA-106b-5p in rheumatoid arthritis.
    Qiu H; Liu M; Shi X; Ma M; Zhang J; Liu H
    Autoimmunity; 2022 Dec; 55(8):567-576. PubMed ID: 36164683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA GAS5 suppresses the migration and invasion of hepatocellular carcinoma cells via miR-21.
    Hu L; Ye H; Huang G; Luo F; Liu Y; Liu Y; Yang X; Shen J; Liu Q; Zhang J
    Tumour Biol; 2016 Feb; 37(2):2691-702. PubMed ID: 26404135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shikonin suppresses progression and epithelial-mesenchymal transition in hepatocellular carcinoma (HCC) cells by modulating miR-106b/SMAD7/TGF-β signaling pathway.
    Li X; Zeng X
    Cell Biol Int; 2020 Feb; 44(2):467-476. PubMed ID: 31617643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. lncRNA MT1JP-overexpression abolishes the silencing of PTEN by miR-32 in hepatocellular carcinoma.
    Zhang S; Xu J; Chen Q; Zhang F; Wang H; Guo H
    Oncol Lett; 2021 Aug; 22(2):604. PubMed ID: 34188706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.